Bioxytran, Inc.
BIXT
$0.07
$0.002.21%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -2.10M | -2.21M | -2.91M | -2.12M | -2.64M |
| Total Depreciation and Amortization | 11.50K | 8.80K | 7.80K | 7.90K | 8.80K |
| Total Amortization of Deferred Charges | 622.80K | 647.80K | 677.80K | 677.80K | 55.00K |
| Total Other Non-Cash Items | 322.60K | 414.40K | 746.20K | 364.90K | 319.90K |
| Change in Net Operating Assets | 902.30K | 865.80K | 1.21M | 858.20K | 1.91M |
| Cash from Operations | -245.40K | -277.40K | -267.00K | -209.30K | -346.00K |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -29.00K | -38.10K | -22.20K | -28.20K | -22.70K |
| Cash from Investing | -29.00K | -38.10K | -22.20K | -28.20K | -22.70K |
| Total Debt Issued | 240.80K | 305.10K | 220.60K | 153.60K | 215.10K |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 13.40K | 0.00 | 63.00K | 63.00K | 108.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 254.10K | 305.10K | 283.60K | 216.60K | 323.10K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -20.10K | -10.30K | -5.60K | -20.90K | -45.60K |